Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 2 (33%) |
| Double-patenting only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAK, YONG D | 1 | 74.6% | +14.3% |
| JADHAO, SAMADHAN JAISING | 1 | 50.0% | +47.1% |
| NGUYEN, QUANG | 1 | 38.1% | +53.0% |
| LEE, ANDREW P | 1 | 48.4% | +23.3% |
| MOLOYE, TITILAYO | 1 | 63.1% | +47.1% |
| REGLAS, GEORGIANA C | 1 | 37.5% | +31.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17290806 | SYSTEM AND METHOD FOR GENOME EDITING BASED ON C2C1 NUCLEASES | REGLAS, GEORGIANA C | 26d |
| 18717976 | ENGINEERED CAS12B EFFECTOR PROTEINS AND METHODS OF USE THEREOF | PAK, YONG D | — |
| 17915964 | ACTIVE DNA TRANSPOSON SYSTEMS AND METHODS FOR USE THEREOF | NGUYEN, QUANG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614303 | COMPOSITIONS AND USE OF ENGINEERED MYOGENIC CELLS | MOLOYE, TITILAYO | 15d overdue |
| 17290806 | SYSTEM AND METHOD FOR GENOME EDITING BASED ON C2C1 NUCLEASES | REGLAS, GEORGIANA C | 26d |
| 18717976 | ENGINEERED CAS12B EFFECTOR PROTEINS AND METHODS OF USE THEREOF | PAK, YONG D | — |
| 18150917 | METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE | JADHAO, SAMADHAN JAISING | — |
| 17915964 | ACTIVE DNA TRANSPOSON SYSTEMS AND METHODS FOR USE THEREOF | NGUYEN, QUANG | — |
| 17639181 | COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF COMPOSITION | LEE, ANDREW P | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1672 | 1 |
| 1631 | 1 |
| 1691 | 1 |
| 1632 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717976 | ENGINEERED CAS12B EFFECTOR PROTEINS AND METHODS OF USE THEREOF | PAK, YONG D | 1652 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18150917 | METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE | JADHAO, SAMADHAN JAISING | 1672 | DP | Non-Final OA | — | Pending | Aug 03, 2023 |
| 17915964 | ACTIVE DNA TRANSPOSON SYSTEMS AND METHODS FOR USE THEREOF | NGUYEN, QUANG | 1631 | §102§112 | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17639181 | COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF COMPOSITION | LEE, ANDREW P | 1691 | §103 | Non-Final OA | — | Pending | Feb 28, 2022 |
| 17614303 | COMPOSITIONS AND USE OF ENGINEERED MYOGENIC CELLS | MOLOYE, TITILAYO | 1632 | §103 | Final Rejection | 15d overdue | Pending | Nov 24, 2021 |
| 17290806 | SYSTEM AND METHOD FOR GENOME EDITING BASED ON C2C1 NUCLEASES | REGLAS, GEORGIANA C | 1651 | §101§112 | Non-Final OA | 26d | Pending | May 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial